Results 131 to 140 of about 88,868 (230)

Urinary Calcium and Phosphorus Excretion in Vitamin D‐Sufficient Preterm Infants: Establishing Age‐Specific Normative Data

Acta Paediatrica, Volume 114, Issue 12, Page 3267-3278, December 2025.
ABSTRACT Aim This study evaluated urinary calcium (Ca) and phosphorus (P) excretion in very low birth weight infants ( < 1500 g, VLBW) without severe morbidity, treated with methylxanthines. Methods Eighty‐one VLBW infants were analysed. Urinary Ca and P and their creatinine ratios were measured biweekly until day 56.
Tomas Matejek, Veronika Pokorna, Vojtech Drahy, Lenka Zaloudkova, Vladimir Palicka, Sylva Skalova   +5 more
wiley   +1 more source

Artificial intelligence aids doctors in diagnosing necrotizing enterocolitis and predicting surgery using abdominal radiographs: a multicenter study. [PDF]

Quant Imaging Med Surg
Li YT, Wu K, Mou YL, Zhong C, Zhang G, Tan RY, Zhang X, Wang JJ, Chen QM, Yu DY, Lu Y, Ding XT, Yang LC.   +12 more
europepmc   +1 more source

Carbamyol phosphate synthetase 1 gene (4217C>A) polymorphism and its relation to low plasma arginine level among preterm with necrotizing enterocolitis; a single center Egyptian study [PDF]

, 2018
Wesam A. Mokhtar
openalex   +1 more source

Core Indicator Set for Measuring Quality of Care in Necrotising Enterocolitis: A European Delphi Study

Acta Paediatrica, Volume 114, Issue 12, Page 3284-3297, December 2025.
ABSTRACT Aim Inconsistent guidelines and practice variations in necrotising enterocolitis (NEC) hamper care improvements. A universally accepted quality indicator set is needed to standardise and improve care throughout Europe. We aimed to establish a core set relevant to NEC patients and experts.
Otis C. van Varsseveld, Irene de Haro Jorge, Daniel Rossi, Marlinde van der Kamp, Mohamed Riadh Boukhris, Miriam Duci, Johannes W. Duess, Simon Eaton, Elisabeth M. W. Kooi, Martin Lacher, Lucas E. Matthyssens, Carmen Mesas Burgos, Marc Miserez, Lorenzo Norsa, Elena Palleri, Rony Sfeir, Marie Spruce, Marijn J. Vermeulen, Jan. B. F. Hulscher, Jordi Prat Ortells   +19 more
wiley   +1 more source

Food protein-induced enterocolitis syndrome &ndash; a review of the literature with focus on clinical management

, 2017
Marine Michelet, Dominique Schluckebier, Laetitia‐Marie Petit, Jean‐Christoph Caubet   +3 more
openalex   +2 more sources

Absence of Evidence of Beneficial Effects of Human Milk‐Based Fortifier: A Bayesian Model‐Averaged Meta‐Analysis

Acta Paediatrica, Volume 114, Issue 12, Page 3309-3316, December 2025.
ABSTRACT Aim Human milk‐based fortifiers (HMBFs) have been adopted in neonatal care despite limited efficacy data. Our objective was to conduct a Bayesian re‐analysis of the current evidence on the protective effect of HMBF against necrotising enterocolitis (NEC, stage II‐III).
Maurice J. Huizing, Giulia Vizzari, František Bartoš, Giacomo Cavallaro, Maria L. Gianni, Eduardo Villamor   +5 more
wiley   +1 more source

Association between hypertensive disorders of pregnancy and disease progression in preterm infants with necrotizing enterocolitis: a retrospective cohort study. [PDF]

Eur J Med Res
Shen L, Lin J, Cui M, Zhang X, Li L, Feng Z, Cai Y, Yang Z.   +7 more
europepmc   +1 more source

The Incidence of Necrotizing Enterocolitis (NEC) Is Increased following Surgical Ligation Versus Indomethacin Treatment of a Patent Ductus Arteriosus (PDA) [PDF]

, 1999
Ann Chen, James M. Adams, E. O’Brian Smith, Leonard E. Weisman   +3 more
openalex   +1 more source

From Trials to Practice: A 2025 Review of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel Efficacy Across Clinical Studies and Real‐World Evidence

European Journal of Haematology, Volume 115, Issue 6, Page 533-546, December 2025.
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez, Sakditad Saowapa, Andrea Ortiz Maldonado, Chanakarn Kanitthamniyom, Diego Olavarria Bernal, Lukman Tijani   +5 more
wiley   +1 more source

Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report database. [PDF]

In Vivo
Kanbayashi Y, Morioka R, Takayama K, Hosohata K.   +3 more
europepmc   +1 more source